<DOC>
	<DOCNO>NCT01499329</DOCNO>
	<brief_summary>The purpose study evaluate safety performance balloon-expandable Zeus CC ( Rontis AG ) stent treatment Trans-Atlantic Inter-Society Consensus ( TASC ) A , B , C D iliac lesion .</brief_summary>
	<brief_title>Safety Performance Zeus CC Stent Treatment Iliac Occlusive Disease</brief_title>
	<detailed_description />
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<criteria>1 . Patient old 18 year 2 . Patient must sign write informed consent form approve ethic committee prior indexprocedure 3 . Patient must compliant followup visit 4 . Patient suffers intermittent claudication ( Rutherford 13 ) critical limb ischemia ( Rutherford 4 5 ) 5 . Patient 's life expectancy 2 year 6 . Patient iliac atherosclerotic de novo lesion ( ) type A , B , C &amp; D accord TASCII classification 7 . Target vessel diameter 5 9 mm 8 . Target lesion baseline diameter stenosis 50 % 9 . Patient sufficient infrainguinal runoff least patent common femoral artery deep femoral artery ( &lt; 50 % stenosis ) 1 . Patient life expectancy le 2 year 2 . Patient refuse compliant followup visit 3 . Patient suffers acute limb ischemia , define sudden decrease limb perfusion cause potential threat limb viability . 4 . Patient intolerant anticoagulant antiplatelet therapy aspirin , heparin , clopidogrel ticlopidine drug therapy 5 . Patient already treat stent ipsilateral target vessel 6 . Patient suffer tissue loss target extremity , define Rutherford 6 7 . Patient already enrol another investigational device study 8 . Patient coronary intervention within last 60 day enrolment study plan coronary intervention within 60 day enrolment study 9 . Use alternative therapy ( e.g . atherectomy , cut balloon , laser , radiation therapy ) part indexprocedure 10 . Any planned surgical intervention within 30 day indexprocedure 11 . Patient abdominal aortic aneurysm likely require repair within next 2 year . 12 . Patient sufficient infrainguinal runoff ( &gt; 50 % stenosis ) . Patient inclusion possible revascularization ( endovascular surgical ) perform procedure peroperative angiographic control yield &lt; 30 % stenosis . 13 . Target lesion restenotic lesion . 14 . Target lesion adjacent aneurysm . 15 . Target vessel perforation document contrast extravasation indexprocedure prior stent placement .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Stent therapy</keyword>
</DOC>